08183505 · Active · incorporated 14 years, 2 months ago · London
Biotech AI Biotech & Life Sciences Drug Discovery Robotics Series B+
LabGenius Therapeutics uses AI, robotic automation, and synthetic biology to accelerate the discovery of therapeutic antibodies.
Labgenius Therapeutics is a private limited company registered at Companies House under number 08183505, incorporated on 17 August 2012, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 101 filings for this company, including 4 funding rounds. Its most recent round closed in February 2026, raising £11.6m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 4 | Feb 2026 | £11.6m | £14.09 |
| Round 3 | Apr 2024 | £25m | £14.09 |
| Round 2 | Oct 2019 | £8.9m | £15.43 |
| Round 1 | Oct 2016 | £2.1m | £9.22 |
Showing the 10 most recent of 101 filings.
See the complete cap table with every shareholder, founder tags, dilution across 17 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.